维普中文期刊产品整合服务
98篇 您的检索式:作者名="Tellingen"
    题名 作者 年代 出处 被引量
1Enhancedlong-term reduction of plasma leptin concentrations bysuper-flux polysulfone dialysers显示文摘van Tellingen A Grooteman MP Schoorl M 2004Nephrol Dial Transplant2004,19,5:1
2long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients显示文摘Van Tellingen A Grooteman MP Ridgway EC 2001Kidney Int2001,59,1:1
3Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients显示文摘 Huizing MT Panday VR 1999Br J Cancer1999,81,2:1
4Rapid esterasesensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokineties of docetaxel and metabolites in mice 显示文摘van Tellingen O Beijnen JH Verweij J 1999Clin Cancer Res1999,5,10:1
5Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833 显示文摘van Asperen J van Tellingen O Sparreboom A 1997Br J Cancer1997,76,9:1
6Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice 显示文摘Van Tellingen O Beijnen JH Verweij J 1999Clin Cancer Res1999,5,10:1
7Role of glutathione in the export of compounds from cells by the multidrugted protein显示文摘ZAMAN G J LANKELMA J VAN TELLINGEN O 1995Proc Natl Acad Sci USA1995,92,17:1
8Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives 显示文摘Van Tellingen O Sips JHM Beijnen JH 1992Anticancer Res1992,12,:1
9Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin–DNA adduct formation in patients and ovarian cancer cell lines显示文摘P.J.M. van de Vaart N. van der Vange F.A.N Zoetmulder A.R. van Goethem O. van Tellingen W.W. ten Bokkel Huinink J.H. Beijnen H. Bartelink A.C. Begg 1997European Journal of Cancer1997,,1:1
10Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs显示文摘Schinkel AH Smit J J van Tellingen O 1994Cell1994,77,4:1
11Disruption of the mouse mdr1a P-Glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs 显示文摘Schinkel AH Smit JJM Tellingen O van 1994Cell1994,77,:1
12Dutch guidelinesfor diagnosis and therapy of proliferative lupus nephritis显示文摘Van Tellingen A Voskuyl AE Vervloet MG 2012Neth JMed2012,70,4:1
13Disruption of the mouse mdr1a Pglycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs显示文摘SCHINKEL AH SMIT JJ TELLINGEN O 1994Cell1994,77,4:1
14Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography显示文摘van Tellingen O Kuijpers AV Beijnen JH 1993Invest New Drugs1993,11,23:1
15Mrp2 (abcc2) Transports taxanes and confers paelitaxel resistance and both processes are stimulated by probenecid显示文摘Huisman MT Chhatta AA Van tellingen O 2005Int J Cancer2005,116,5:1
16Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice 显示文摘TELLINGEN O V BEIJNEN J H VERWEI J J 1995Clin Cancer Res1995,5,10:1
17Bmi1 Controls Tumor Development in an Ink4a/Arf-Independent Manner in a Mouse Model for Glioma显示文摘Sophia W.M. Bruggeman Danielle Hulsman Ellen Tanger Tessa Buckle Marleen Blom John Zevenhoven Olaf van Tellingen Maarten van Lohuizen 2007Cancer Cell2007,,4:1
18Tissue distribution, metabolism and excretion of paclitaxel in mice显示文摘Sparreboom A van Tellingen O Nooijen WJ 1996Anti Cancer Drugs1996,7,1:1
19Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil显示文摘Linn SC van Kalken CK van Tellingen O 2004J Clin Oncol2004,12,4:1
20Disruption of the mouse mdrl a P- glycoprotein gene leads to a deficiency in the blood - brain barrier and to increased sensitivity to drugs 显示文摘Schinkel AH Smit JJ van Tellingen O 1994Cell1994,77,4:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费